The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group (Q41718417)
Jump to navigation
Jump to search
scientific article published on January 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group |
scientific article published on January 2000 |
Statements
1 reference
The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group (English)
1 reference
Sall K
1 reference
1 January 2000
1 reference
1 reference
44 Suppl 2
1 reference
S155-62
1 reference
Identifiers
1 reference
1 reference